Prof. Donna Dickenson University of London

Slides:



Advertisements
Similar presentations
M ITOCHONDRIAL GENOME REPLACEMENT IN UNFERTILIZED OOCYTES FOR TREATMENT OF INHERITED MT DNA DISEASE Shoukhrat Mitalipov 1.
Advertisements

HART RESEARCH P e t e r D ASSOTESCIA Massachusetts Voters On Stem Cell And SCNT Research Survey among 606 likely voters in Massachusetts Conducted March.
Human Embryo Research James G. Anderson, Ph. D Purdue University.
STEM CELL RESEARCH - Basics
Use of Embryos : Reproductive LI: I can describe how embryos can be used to help develop reproduction. Success: I have completed notes on IVF, PGD/PGS,
In Vitro Fertilization and Preimplantation Genetic Diagnosis
In Vitro Fertilisation (IVF) IVF enables fertilisation, outside the body, in a culture dish.
Living with mitochondrial disease and responses to novel (and controversial) reproductive technologies Dr Rebecca
What’s in a name? Identifying multiple representations of women who provide eggs for mitochondrial research. Erica Haimes and Ken Taylor PEALS Research.
Meet The Parents. Jack and Jill went up a hill…. Jack and Jill got married.
Jayanti Tokas, MS, PhD 1 ; Rubina Begum, MS. PhD 1 ; Shalini Jain, MS, PhD 2 and Hariom Yadav, MS, PhD 2 1 Department of Biotechnology, JMIT, Radaur 2.
Miri Seminar Tufts University April 18, 2014 Genetically Designed Babies & Mitochondrial Disease.
The genetic counsellor When there is a possibility that a couple may have a child with a genetic disease, they may be referred to a genetic counsellor.
Designer Babies and Genetic Engineering
Genetic Enhancement Note: For use after GATTACA. Genetic enhancement has emerged as an ethical issue because it involves the power to redesign ourselves.
© Michael Lacewing The rise of the clones? Michael Lacewing
Medicine. By inserting a gene for human insulin into an E.Coli bacterium, the E. coli will make lots of insulin, which scientists and doctors can collect.
Nucleus Mitochondria Chromo- somes. Mitochondrial Diseases Organs with high energy needs tend to be most severely affected e.g. muscle, brain, eyes,
How can Science and Technology Help and Hurt Humanity ?
4.4: Genetic Engineering and Biotechnology Cloning: producing identical copies of genes, cells or organisms. Clone: a group of genetically identical organisms.
SCAN – Stem Cell Action Network
Case study 1 Helen wants a child. She isn't aiming to create a perfect child but she wants to undergo genetic selection treatment. Helen has a problem.
Human Embryo Research – informing regulatory policy Professor Neva Haites Vice Principal of University of Aberdeen Member of the Human Fertilisation and.
 Cloning is creating a plant, animal, or person asexually. They is genetically identical with a donor plant, animal, or person.  There are two major.
Experimental Gene Therapy Use On Humans. What is gene therapy? Gene therapy is a method of curing genetic disorders by introducing functioning genes into.
Liberal /Protestant view Situation ethics / Use the science/technology for good / Embryos are not human life until after 14 days Fertility treatment Jesus.
In Vitro Fertilisation (IVF) IVF enables fertilisation, outside the body, in a culture dish.
Therapeutic avenues Louise Hyslop. 1. Reproductive technologies to prevent transmission of mitochondrial DNA disease 2. Clinical trials and potential.
What is it? Mammal cloning is the process of taking somatic cells from a donor (cannot be nerve cells from CNS or red blood cells because they do not.
1 III Cloning. 2 Robertson’s Project Robertson considers human cloning from the point where Pence left us: with a program of cloning that is safe and.
What is gene therapy? Do now: In your own words,
Stage 1 Biology Semester Biotechnology
The French Perspective The law 1994 Civil code: Art
Human Embryos and Gene-editing Research and regulation in China Prof. Zhihong Xu, Peking University & Chinese Academy of Sciences.
HFEA Medical Ethics: Embryo. Learning Intentions 0 Be able to explain the legal status of the human embryo in UK law. 0 Be able to describe the role of.
 What if you could screen embryos for diseases before they became babies?  What if you could choose the traits your baby would have?  Would you use.
Genome editing: What lessons can we learn from the mitochondrial donation debate? Peter Thompson Human Fertilisation & Embryology Authority.
5.2 Cloning. Clones in Fiction Frau Farbissina: “Send in the clone!” Dr. Evil: “Oh!” Number One: “He is exactly like you in every way, except one-eighth.
Germline genetic engineering and ‘mitochondrial transfer’ Prof. Donna Dickenson.
G E N E T I C E N G I N E E R I N G By Szymon Stańczak.
What are Christian views on fertility treatment?
There are numerous reasons to use eugenics and customize your child’s genes. It can be for desired capability in certain areas as well as to keep children.
The hope (and hype) of reproductive technologies: mitochondria disease and techniques of mitochondria donation Dr Rebecca Dimond
Matters of life Religion, morality & life; Fertility treatment;
What do we need to know to become stem cell literate?
Assisted Reproductive Technology (ART)
Cloning BY Jaiden lovell.
Cloning.
The nature of genetic engineering (cloning)
Religious attitudes to matters of life
Genes in the News: Making Babies with 3 Genetic Parents
Genetic Engineering and Animal Research
Gene Editing: Ethics and Governance
On Human Gene Editing: International Summit Statement
Preimplantation Genetic Diagnosis (PGD)
Gene Therapy Presentation brought to you by: Therapeutic Genes Inc.
Ethics in Biotechnology
REPRODUCTIVE TECHNOLOGIES
Therapeutic –vs- Reproductive Cloning
Module 6.4 Cloning & Biotechnology
CREATING LIFE….
DNA and the Genome Key Area 4b Stem Cells.
What are stem cells? Click on the title to watch the intro video!
27 Nov, 2018 The University of Hong Kong
Therapeutic –vs- Reproductive Cloning
Subcommittee on Genetic Modification Representative Nathaniel Smith
3 parents Student sheets Sheet no. Title Notes SS1 All about LHON
CRISPR Babies: Background and Ethics
Presentation transcript:

Prof. Donna Dickenson University of London The burning question in the UK: ‘mitochondrial replacement’ research and public policy Prof. Donna Dickenson University of London

A new and crucial development New target for ART: not infertile couples ‘Mitochondrial replacement’ (MR) would allow fertile women with mitochondrial disease to have genetically related children who would not be at risk (since disease passes through maternal line) Fact that it requires large quantities of eggs ignored by many commentators (‘sliver of DNA’) Egg donation issue not being framed in terms of either altruism or commercialisation, but simply avoided altogether

Chronology October 2012: Oregon scientists (Mitalipov et al.) publish key Nature paper on MR in 5 macaques, followed by UK research (Herbert et al.) June 2013: UK government proposes regulatory changes to allow MR, although HFEA consultation finds majority of public opposed. Expert panel says no evidence techniques unsafe. February 2014: US FDA hearings, however, conclude that ‘the full spectrum of risks has yet to be identified’ and that both basic and clinical science not far enough advanced to legalise MR

Chronology continued March 2014: MPs of both parties speak against proposals. Government repeats that it intends to allow MR and will only allow debate on how trials will be regulated, but later has to modify position to allow conscience vote in Parliament. Another poll undermines official claim that public in favour. HFEA opens final scientific evidence call on safety but allows only two weeks for submissions. May 21, 2014: Final consultation on draft regulations ends. What next?

What is ‘mitochondrial replacement’? Term is actually inaccurate, masking contribution of egg donor and egg’s role in programming DNA What is being transferred is not the 37 genes in mitochondria, but somatic cell (with some 20,000 genes) from a woman affected with mitochondrial disease to another woman’s healthy egg, from which nucleus has been removed; really ‘nuclear transplantation’ Preliminary research (Mitalipov et al.) used 106 eggs from 7 women, one of whom donated 28 eggs, indicating possible ovarian hyperstimulation

More on mitochondrial disease Mithochondria sometimes described as the energy ‘batteries’ (piles) of the cell One in 200 babies born with some mitochondrial disorder, but majority are healthy. Better estimate for severe disease is about one in 6500. Can cause muscle weakness, heart, kidney and liver disease, and neurological disorders Expected number of treatments: only 10 cases p.a., depending on cost (probably around £80,000)

So why this controversy over such a small number of cases? UK proposals fly in face of international agreement against germline genetic modification (e.g. Oviedo Convention) The fact that the US regulator has come out against the technology hasn’t been publicised in UK (cf my New Scientist article) Opponents are being portrayed as either pro-Catholic, anti-science, or both, although many scientists are sceptical Democratic consultative process has been flawed

Scientific evidence base FDA: Apart from risks to egg donor and recipient, possible mutations from incompatibility between DNA of somatic cell donor and egg donor Because only one study to date has used human eggs or embryos containing abnormal mitochondria, too early to judge effectiveness. Other studies showed abnormalities in human zygotes not found in monkeys. Although UK Chief Medical Officer calls it ‘life-saving treatment’, technique cannot cure any existing sufferers; unclear whether‘bad’ mitochondria might reappear in later generations

Ethical concerns: 1. Altering DNA of future generations Consultation document acknowledges that ‘the treatment techniques are akin to germline therapy to the extent that mitochondrial donation may have implications not only for the children born as a result of the procedure but for their descendants’ Although this might seem a change for the better, too little is known about long-term risks Slippery slope towards other forms of alteration?

2. Risks for recipients US professor David Keefe has written to HFEA in these terms: ‘Displays of technical virtuosity should not blind us to potential hazards…Our own group moved away from this research because PGD (preimplantation genetic diagnosis, DPI) provides a relatively safe alternative to MR for the majority of patients and because vexing concerns linger about the safety of MR.’ In any case, women with severe mitochondrial disease might be too ill to endure pregnancy (FDA patient witnesses)

3. For donors: parentage, consent and exploitation Three or even four parents, if surrogate required because recipient too ill: questions downplayed in UK as sensationalistic, but although technique would probably not be permitted in France, where questions about projet parental are legitimate Donor’s contribution of labour and risk-taking is being ignored. ‘Lady vanishes’: common phenomenon in stem cell research as well Is altruism of donors being exploited? Can’t give truly informed consent in absence of long-term information about risks of technique

Country comparisons Neo-liberal, science-led approval process for trials now being pushed through in UK contrasts not only with principled conservatism of French regulation but even with cautious findings of US FDA hearings Consultation only concerns ‘the detail of the regulations that would put into effect the Government’s intention to allow it’ (s. 2.4 of document). Fait accompli? Actually UK government being very dirigiste despite UK’s libertarian reputation abroad

Mobilisation of patient groups Mehl identifies this as crucial difference between 1994 and 2011 French debates, but scepticism about how genuine Etats-generaux de bioethique really were In US patient representatives did testify, but against new technique

En somme… Consultation document, annex C: ‘The intended effects of the proposal are: A. To enable safe and effective treatment for mitochondrial disease But neither safety nor efficacy is yet established, and this is not treatment: at most prevention.

B. Second aim B. ‘To ensure that only those mothers with a significant risk of having children with severe mitochondrial disease would be eligible for treatment’ But these might well be the very severely affected women for whom the risks of pregnancy would be too great

C. The heart of the matter ‘To signal the UK’s desire to be at the forefront of cutting edge of medical techniques’ But as any aficionado of spaghetti westerns knows, the frontier can be a lonely and dangerous place